Jamieson Laboratories Ltd in Consumer Health (Canada) - new co...In a difficult operating environment, the manufacturer focuses on better performing categories and places stronger emphasis on scientific support behind its product release and health claims, such as its new 10mg melatonin product whose launch was ... TransWorldNews, 1 day ago
Alkem Laboratories Ltd.: New Alkem Laboratories Ltd. company profile published
- TransWorldNews, 2 days ago
|
55 images for laboratories ltd | ||||
Daiichi may initiate legal action against former Ranbaxy shareholdersMUMBAI/NEW DELHI -- Daiichi Sankyo Co. Ltd, the Japanese parent of Ranbaxy Laboratories Ltd, said on Wednesday that it may initiate legal action against certain former shareholders of the Indian generic drug maker for concealing and misrepresenting ... Individual.com, 1 day ago
Daiichi Sankyo pursuing legal remedies against former Ranbaxy owners
KeralaNext.com, 1 day ago
Daiichi pursuing legal action on ex-shareholders
Smart Investor, 1 day ago
|
Jyothy Labs Q4 net falls 57.70%FMCG firm Jyothy Laboratories Ltd on Wednesday reported a fall of mote than 57 per cent in consolidated net profit for the quarter ended March 31. The maker of popular fabric whitener Ujala reported that its consolidated net profit during the ... Topnews.in, 1 day ago
BRIEF: Jyothy Labs Q4 profit falls 57.70%
Individual.com, 1 day ago
|
Ranbaxy shares down on $500m fine to settle U.S. drug safety chargesRanbaxy Laboratories Ltd (RANB.NS) shares were down over 1 percent in early trade on Tuesday after the generic drugmaker pleaded guilty to U.S. felony charges related to drug safety and will pay $500 million in civil and criminal fines. The settlement is its ... The Financial Chronicle, 1 week ago
Ranbaxy shares dive over 9% on bourses in morning trade
Indian Express, 1 day ago
US: Ranbaxy shares down on $ 500 mn fine
IBN Live, 1 week ago
Ranbaxy shares slump on $500 mln fine to settle US drug safety charges
Sify, 1 week ago
More from: , Business Standard...and 1 other sources
|
Divis Laboratories Q4 PAT down to Rs. 180.57 croreDivis Laboratories Ltd has announced the financial results for the quarter & year ended March 31, 2013.The Company has posted a net profit of Rs. 1818.30 million for the quarter ended March 31, 2013 as compared to Rs. 2147.80 million for the quarter ... Equity Bulls, 2 days ago
Jyothy Lab Q4 net profit at Rs 11.81 crore
Hindu Business Line, 2 days ago
Divis Laboratories profit dips
Hindu Business Line, 4 days ago
Divis Laboratories Q4 net profit at Rs1805.70 mn
India Infoline, 3 days ago
|
Dr Reddys welcomes new pharma pricing policyRelated to : Dr Reddys Laboratories Ltd Dr Reddys Laboratories Ltd BSE 17 May 13 | 12:00 AM 2077.65 -38 (-1.8%) NSE 17 May 13 | 12:00 AM 2078.30 -40.65 (-1.92%) Hyderabad-based pharmaceutical major Dr Reddy's Laboratories Limited has welcomed ... Smart Investor, 6 days ago
Dr Reddys says have factored in the impact
Business Line, 1 week ago
LIC offloads 2.13% stake in Dr Reddys Lab
Business Line, 1 week ago
NSE index hits 28-month high
Sify, 1 week ago
More from: , Andhra News...and 2 other sources
|
Buy Unichem Laboratories for the target price of Rs 203: FirstcallUnichem Laboratories Ltd is engaged in manufacturing formulations, active pharmaceutical ingredients (APIs) and pharmaceuticals Sify, 1 week ago
Hold Ipca Laboratories: Pankaj Jain
Money Control, 1 week ago
Buy Dhanuka Agritech for the target price of Rs 134: Firstcall
Sify, 2 months ago
Buy Caplin Point Laboratories for the target price of Rs 76: Firstcall
Sify, 2 months ago
|
Divi's Lab tanks over 6% on weak earnings | QuoteNEW DELHI: Divi's Laboratories Ltd slipped over 6 per cent in morning trade on Tuesday, after the company posted 16.75 per cent decline in its consolidated net profit at Rs 180.57 crore for the fourth quarter ended March 31, 2013. At 10:50 a.m.; the ... Economic Times, 3 days ago
Divi's Laboratories tanks over 6 on weak Q4 earnings downgrade
New Delhi News.Net, 3 days ago
|
Ranbaxy shares slump after Daiichi Sankyo says misled over probesMUMBAI, May 23 (Reuters) - Ranbaxy Laboratories Ltd slumped as much as 6.6 percent on Thursday after majority shareholder Daiichi Sankyo Co said it believes former shareholders of the Indian company hid information regarding U.S. regulatory probes. Sharenet, 1 day ago
Daiichi Sankyo accusation 'false and baseless': Singhs
Business Standard India, 22 hours ago
Daiichi Sankyo accusation "false and baseless": Singhs
First Post.com, 1 day ago
UPDATE 1-Ranbaxy slumps after Daiichi Sankyo says was misled
Reuters, 1 day ago
|
Ranbaxy reinforces dedication to provide safe, quality medications globallyRanbaxy Laboratories, Ltd., which was involved in a recall of Atorvastatin, the generic form of Lipitor, issued a press release to address certain conduct of the past.In a press release dated May 22, Ranbaxy, Ltd., which is Examiner.com, 1 day ago
Ranbaxy Highlights Improved Business and Quality Assurance Standards
Scottrade, 2 days ago
Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an
Gnom.es, 1 day ago
Ranbaxy Laboratories (RANBAXY.BO) Highlights Improved Business and Quality Assurance Standards
BioSpace, 1 day ago
|